Autolus Therapeutics (AUTL) Accumulated Depreciation & Amortization (2017 - 2025)
Historic Accumulated Depreciation & Amortization for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $6.2 million.
- Autolus Therapeutics' Accumulated Depreciation & Amortization rose 913.28% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 913.28%. This contributed to the annual value of $7.6 million for FY2024, which is 1506.47% up from last year.
- Latest data reveals that Autolus Therapeutics reported Accumulated Depreciation & Amortization of $6.2 million as of Q3 2025, which was up 913.28% from $4.1 million recorded in Q2 2025.
- Over the past 5 years, Autolus Therapeutics' Accumulated Depreciation & Amortization peaked at $8.5 million during Q4 2021, and registered a low of $1.8 million during Q1 2024.
- For the 5-year period, Autolus Therapeutics' Accumulated Depreciation & Amortization averaged around $4.9 million, with its median value being $5.2 million (2023).
- Per our database at Business Quant, Autolus Therapeutics' Accumulated Depreciation & Amortization skyrocketed by 4948.75% in 2021 and then plummeted by 1702.75% in 2023.
- Autolus Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $8.5 million in 2021, then decreased by 12.25% to $7.4 million in 2022, then fell by 11.55% to $6.6 million in 2023, then grew by 15.06% to $7.6 million in 2024, then fell by 18.53% to $6.2 million in 2025.
- Its Accumulated Depreciation & Amortization was $6.2 million in Q3 2025, compared to $4.1 million in Q2 2025 and $2.0 million in Q1 2025.